NeuroPace goes public on Nasdaq, raising $117.3 million gross

NeuroPace

NeuroPace priced its initial public offering at $17 per share on April 22, 2021, raising $117.3 million in gross proceeds (6.9 million shares including underwriter options). The company opened at $24.96 on its first trading day on the Nasdaq Global Select Market.